Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Becker

Showing results (211-220 of 274) with videos related to

Pageof 28
Sort By:
Vaccine|June 6, 2017
ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in miceNaif Khalaf Alharbi, Eriko Padron-Regalado, Craig P Thompson, et al.
Journal of Immunological Methods|January 7, 2021
Development and characterization of an indirect ELISA to detect SARS-CoV-2 spike protein-specific antibodiesVerena Krähling, Sandro Halwe, Cornelius Rohde, et al.
The Journal of Infectious Diseases|October 12, 2019
Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein Nanoparticle Vaccine With Matrix-M Adjuvant in Healthy AdultsLouis Fries, Iksung Cho, Verena Krähling, et al.
Cell Reports|August 31, 2017
Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOVAnne Rechtien, Laura Richert, Hadrien Lorenzo, et al.
The European Respiratory Journal|July 4, 2020
Cyclophilin inhibitors restrict Middle East respiratory syndrome coronavirus <i>via</i> interferon-λ <i>in vitro</i> and in miceLucie Sauerhering, Alexandra Kupke, Lars Meier, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 28, 2022
Self-amplifying RNA vaccine protects mice against lethal Ebola virus infectionVerena Krähling, Stephanie Erbar, Alexandra Kupke, et al.
Science (New York, N.Y.)|December 4, 2003
Phylogeny of the SARS coronavirusMarkus Eickmann, Stephan Becker, Hans-Dieter Klenk, et al.
Frontiers in Immunology|January 3, 2025
MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact subsequent adaptive immunityIlka Grewe, Monika Friedrich, Marie-Louise Dieck, et al.
The Journal of Infectious Diseases|December 6, 2007
Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratoriesMarcus Panning, Thomas Laue, Stephan Olschlager, et al.
Nature Communications|September 21, 2021
Multi-level inhibition of coronavirus replication by chemical ER stressMohammed Samer Shaban, Christin Müller, Christin Mayr-Buro, et al.
Pageof 28

Showing results (211-220 of 274) with videos related to

Sort By:
Pageof 28
Vaccine|June 6, 2017
ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in miceNaif Khalaf Alharbi, Eriko Padron-Regalado, Craig P Thompson, et al.
Journal of Immunological Methods|January 7, 2021
Development and characterization of an indirect ELISA to detect SARS-CoV-2 spike protein-specific antibodiesVerena Krähling, Sandro Halwe, Cornelius Rohde, et al.
The Journal of Infectious Diseases|October 12, 2019
Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein Nanoparticle Vaccine With Matrix-M Adjuvant in Healthy AdultsLouis Fries, Iksung Cho, Verena Krähling, et al.
Cell Reports|August 31, 2017
Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOVAnne Rechtien, Laura Richert, Hadrien Lorenzo, et al.
The European Respiratory Journal|July 4, 2020
Cyclophilin inhibitors restrict Middle East respiratory syndrome coronavirus <i>via</i> interferon-λ <i>in vitro</i> and in miceLucie Sauerhering, Alexandra Kupke, Lars Meier, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 28, 2022
Self-amplifying RNA vaccine protects mice against lethal Ebola virus infectionVerena Krähling, Stephanie Erbar, Alexandra Kupke, et al.
Science (New York, N.Y.)|December 4, 2003
Phylogeny of the SARS coronavirusMarkus Eickmann, Stephan Becker, Hans-Dieter Klenk, et al.
Frontiers in Immunology|January 3, 2025
MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact subsequent adaptive immunityIlka Grewe, Monika Friedrich, Marie-Louise Dieck, et al.
The Journal of Infectious Diseases|December 6, 2007
Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratoriesMarcus Panning, Thomas Laue, Stephan Olschlager, et al.
Nature Communications|September 21, 2021
Multi-level inhibition of coronavirus replication by chemical ER stressMohammed Samer Shaban, Christin Müller, Christin Mayr-Buro, et al.
Pageof 28